CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Results of operations
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-4/A Deal Registration Statement - Business Combination
- UPLOAD Other SEC-generated Letter
- S-4 Deal Registration Statement - Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Delisting notice
- 10-K Report Annual Report
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Results of operations
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- SC 13G/A Stake Amended Statement of Ownership
- 4 Shares withheld for taxes EVP, CMO gave up 3,369 shares (to pay taxes)
- 4 Shares withheld for taxes CFO gave up 1,021 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 9,690 shares (to pay taxes)
- 8-K Event Other events
- 425 Deal Prospectus/Communication re Business Combination
Page 31 of 68 · 1,358 filings